SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-056850
Filing Date
2024-05-09
Accepted
2024-05-09 16:02:15
Documents
15
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20240509.htm   iXBRL 8-K 40798
2 EX-99.1 meip-ex99_1.htm EX-99.1 39118
3 GRAPHIC img183464774_0.jpg GRAPHIC 80752
4 GRAPHIC img183464774_1.jpg GRAPHIC 67214
5 GRAPHIC img183464774_2.jpg GRAPHIC 50787
  Complete submission text file 0000950170-24-056850.txt   471765

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20240509.xsd EX-101.SCH 23892
18 EXTRACTED XBRL INSTANCE DOCUMENT meip-20240509_htm.xml XML 4524
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 24930322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)